Thyroid function tests: A review

European Review for Medical and Pharmacological Sciences

Volumn 13, Issue 5, 2009, Pages 341-349

  Shivaraj, Gowda ^a   Desai Prakash, B ^a   Sonal, V ^a   Shruthi, K ^a   Vinayak, H ^a   Avinash, M ^a  

^a JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

Author keywords

Free thyroxine; Serum calcitonin; Serum thyroglobulin; Serum total thyroxine; Thyroid stimulating hormone

Indexed keywords

3,3',5' TRIIODOTHYRONINE; ANTITHYROID AGENT; CALCITONIN; ESTROGEN; IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; MICROSOME ANTIBODY; MOLECULAR MARKER; PENTAGASTRIN; PERTECHNETIC ACID TC 99M; PROTEIN TYROSINE KINASE INHIBITOR; PROTON PUMP INHIBITOR; RADIOACTIVE IODINE; RADIOISOTOPE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN; THYROXINE;

ABSENCE OF SIDE EFFECTS; ANAMNESIS; ASPIRATION BIOPSY; CALCITONIN BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; ECHOGRAPHY; ELASTOGRAPHY; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HASHIMOTO DISEASE; HISTOLOGY; HORMONE SYNTHESIS; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE 131 UPTAKE TEST; LIOTHYRONINE BLOOD LEVEL; LYMPHADENECTOMY; LYMPHOCYTIC THYROIDITIS; MOLECULAR GENETICS; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SEROLOGY; SERUM; SINGLE DRUG DOSE; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

CALCITONIN; HUMANS; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID HORMONES; THYROID NEOPLASMS; THYROTROPIN; TUMOR MARKERS, BIOLOGICAL;

EID: 70450179320     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. ROY EW, SHARON YW, SAMUEL R. Diagnostic Tests of the Thyroid, In: DeGroot LJ, Leslie J, Jameson JL et al, eds. Endocrinology, volume 2, 5th edition. USA: Elsevier Saunders, 2006, pp 1899-1913.
2. KOUTRAS DA. Disturbances of menstruation in thyroid disease. Ann NY Acad Sci 1997; 816: 280-284.
3. CARL AB, EDWARD RA, DAVID EB. Reference information for Clinical Laboratory. Table 56-1 Reference intervals and values, In: Burtis, Carl A, Ashwood, Edward R et al, eds. Tietz textbook of Clinical Chemistry and Molecular diagnostics, 4th edition. USA: Elsevier Saunders, 2006, p 2298.
4. CHONCHOL M, LIPPI G, SALVAGNO G, ZOPPINI G, MUGGEO M, TARGHER G. Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1296-1300.
5. WELLE S, O' CONNELL M, DANFORTH E JR, CAMPBELL R. Decreased free fraction of serum thyroid hormones during the carbohydrate overfeeding. Metabolism 1984; 33: 837-839.
6. DAS BK, BARAL N, SHYANGWA PM, TOORA BD, LAMSAL M. Altered serum levels of thyroxine, triiodothyroinine and thyroid stimulating hormone in patients with depression. Kathmandu Univ Med J 2007; 5: 330-334.
7. DUMITRESCU AM, LIAO XH, BEST TB, BROCKMANN K, REFETOFF S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004; 74: 168-175.
8. DUMITRESCU AM, LIAO XH, WEISS RE, MILLEN K, REFERTOFF S. Tissue-specific thyroid hormone deprivation and excess in monocarboxylate trans porter (mct)8-deficient nice. Endocrinology 2006; 147: 4036-4043.
9. PETER AS. Clinical Approach to thyroid Function Testing. In: Stephen A. Falk eds Thyroid Disease: Endocrinology, surgery, nuclear medicine and radiotherapy, 2 edition. Philadelphia: Lippincott- Raven Publishers, 1997, pp 41-52.
10. SURKS MI, CHOPRA IJ, MARIASH CN, NICOLOFF JT, SOLOMON DH. American Thyroid Association Guidelines for use of laboratory tests in thyroid disorders. JAMA 1990; 263: 1529-1532.
11. FITZGERALD PA. Endocrinology, Disease of Thyroid gland. In: Maxin AP, Stephen JMP, Lawrence M et al, eds. Current Medical diagnosis and treatment, 49th edition. USA: Mc Graw Hill publication; 2007, pp 1138-1142.
12. CAROLE S. Assay of thyroid hormones and related. Thyroid and its disease: last revised by February 6, 2004.
13. EKINS R. Measurement of free hormones in blood. Endocrine Rev 1990; 1: 5-6.
14. SZKUDLINSKI MW, KAZLAUSKAITE R, WEINTRAUB BD. Thyroid-stimulation Hormone and Regulation of thyroid Axis, In: DeGroot LJ, Leslie J, Jameson JL et al, eds. Endocrinology, volume 2, 5th edition. USA: Elsevier Saunders, 2006, pp 1803- 1860.
15. GURNEL M, PAOLOBECK P, CHATTERJEE VK. Resistance to Thyroid Hormone, In: DeGroot LJ, Leslie J, Jameson JL et al, eds. Endocrinology, volume 2, 5th edition. USA: Elsevier Saunders, 2006, pp 2227-2234.
16. DELANGE F, CAMUS M, ERMANS AM. Circulating thyroid hormones in endemic goiter. J Clin Endocrinol Metab 1972; 34: 891-895.
17. SADOW PM, CHASSANDE O, SADOW, KOO EK, GAUTHIER K, SAMARUT J, XU J, O'MALLEY BW, WEISS RE. Regulation of expression of thyroid hormone receptor isoforms and coactivators in liver and heart by thyroid hormone. Mol Cell Endocrinol 2003; 203(1-2): 65-75.
18. KOENIG RJ. Ubiquitinated deiodinase: not dead yet. J Clin Invest 2003; 112: 145-147.
19. NELSON JC, TOMEI RT. Direct determination of free thyroxin in undiluted serum by equilibrium dialysis/radioimmunoassay. Clin chem 1988; 34: 1737-1744.
20. CHOPRA IJ. A radioimmunoassay for measurement of 3,3′,5′- triiodothyronine (reverse T3). J Clin Invest 1974; 54: 583-592.
21. CHOPRA U. A radioimmunoassay for measurement of 3, monoiodothyronine. J Clin Endocrinol Metabol 1980; 51: 117-123.
22. WARTOFSKY L, DICKEY RA. Controversy in clinical endocrinology: the Evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrin Metab 2005; 90: 5483-5488.
23. KENDE M, KANDAPU S. Evaluation of thyroid stimulating hormone (TSH) alone as a first-line thyroid function test (TFT) in Papua New Guinea. PNG Med J 2002; 45: 197-199.
24. SPENCER CA. Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clin Proc 1988; 63: 1214-1222.
25. JOSEPH M, ROTMAN-PIKIELNY P, MICHAEL S. Serum Thyrotropin Measurement in the community: Five year follow up in a large network of primary care physicians. Arch Intern Med 2007; 167: 1533-1538.
26. VANHERLE AJ, ULLER RP. Elevated serum Thyroglobulin-A marker of metastases in differentiated thyroid carcinomas. J Clin Invest 1975; 56: 272-277.
27. ARAS G, GULTEKIN SS, KUCUK NO. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer. Nucl Med Commun 2008; 29: 880-884.
28. OZATA M, SUZUKI S, MIYAMOTO T, LIU RT, FIERRO-RENOY F, DEGROOT U. Serum Thyroglobulin in the follow- up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 1994; 79: 98-105. (Pubitemid 24221167)
29. MIRD/DOSE ESTIMATE REPORT NO 8: Summary of Current radiation dose estimates to humans from 99mTc as sodium pertechnetate. J Nucl Med 1976; 17: 74-77.
30. MODIFIED FROM DEGROOT LJ, REEDLARSEN P, HENNEMANN G, et al. Thyroid and its diseases. New York: John Wiley and Sons, 1984.
31. BLUM M. Thyroid imaging In: DeGroot LJ, Leslie J, Jameson JL et al, eds. Endocrinology, volume 2, 5th edition. USA: Elsevier Saunders, 2006, pp 1963-1977.
32. RAMOS CD, ZANTUT-WITTMANN DE. Thyroid suppression test with L-thyroxine and [99mTc] pertechnetate Clinical endocrinology 2000; 52: 471-477.
33. EUSEI R. Routine serum calcitonin measurement in the evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008; 22: 941-953.
34. KARGES W, DRALLE H, RAUE F, MANN K, REINER C, GRUSSENDORF M, HÜFNER M, NIEDERLE B, BRABANT G, GERMAN SOCIETY FOR ENDOCRINOLOGY (DGE)-THYROID SECTION. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 2004; 112: 52-58.
35. CHEUNG K, ROMAN SA, WANG TS, WALKER HD, SOSA JA. Calcitonin measurement in the evaluation of thyroid nodules in the United States a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 2008; 93: 2173-2180.
36. HAHM JR, LEE MS, MIN YK, LEE MK, KIM KW, NAM SJ, YANG JH, CHUNG JH. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 2001; 11: 73-80.
37. MILLER JM, HAMBURGER Jl, KINI S. Diagnosis of thyroid nodules.Use of fine needle aspiration and needle biopsy. JAMA 1979; 241: 481-484. (Pubitemid 9228140)
38. UMA H, SUKANT G, HARSH M, et al. Role of fine needle aspiration cytology in diagnosis and ¬management of thyroid lesions: A study on 434 patients. J Cytology 2008; 25: 13-17.
39. PACINI F, DEGROOT LJ. THYROID NEOPLASIA IN: DEGROOT LJ, LESLIE J, JAMESON JL, et al, eds. Endocrinology, volume 2, 5th edition. USA: Elsevier Saunders, 2006, pp 2147-2180.
40. YURI E. NIKIFOROV, DAVID L. STEWARD, TONI M. ROBINSON-SMITH, BRYAN R. HAUGEN, JOSHUA P. KLOPPER, ZHAOWEN ZHU, JAMES A. Fagin, Mercedes Falciglia, Katherine Weber, Marina N. Nikiforova. Molecular Testing for Mutations in Improving the Fine Needle Aspiration Diagnosis of Thyroid Nodules. J Clin Endocrinol Metab 2009; 10.1210/jc.0247. Published online on March 24, 2009.
41. HIGGINS CB, AUFFERMANN W. MR imaging of thyroid and parathyroid glands-A review of current status. Am J Roentgenol 1988; 151: 1095-1106.
42. TENNVALL J, BIORKLUND A, MOLLER T, et al. Studies of MRI relaxation times in malignant and normal tissues of the human thyroid gland. Prog Nucl Med 1984; 8: 142-148.
43. GOTWAY MB, HIGGINS CB. MR imaging of the thyroid and parathyroid glands. Magn Reson Imaging Clin N Am 2000; 8: 163-182.
44. MACDOUGALL IR. Positron emission tomography in well differentiated thyroid cancer. In: Leonard W, Douglas VN. Thyroid cancer - A comprehensive guide to clinical management. 2nd edition. Place: Humana Press, 2006, pp. 319-328.
45. ROBBINS RJ, LARSON SM. The value of positron emission tomography (PET) in the management of patients with thyroid cancer. Best Pract Res Clin Endocrinol Metab 2008; 22: 1047-1059.
46. NIX P, NICOLAIDES A, COATESWORTH AP. Thyroid cancer review 1-presentation and investigation of thyroid cancer. Int J Clin Pract 2005; 59: 1340-1344. (Pubitemid 43904506)
47. ND ANNUAL MEETING, EUROPEAN THYROID ASSOCIATION. Germany, 2007: September 1-5. Horm Res 2007; 68: 1-91.
48. NIKIFOROVA MN, CHIOSEA SI, NIKIFOROV YE. MicroRNA expression profiles in thyroid tumors. Endocr Pathol 2009; 20: 85-91.
49. SALAJEGHEH A, PETCU EB, SMITH RA, LAM AK. Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Review article PG medical Journal-continuing professional development 2008; 84: 78-82.
50. RAGO T, SANTINI F, SCUTARI M, PINCHERA A, VITTI P. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metabol 2007; 92: 2917-2922. (Pubitemid 47236350)
51. CHIA S, MILAS M, REDDY SK, SIPERSTEIN A, SKUGOR M, BRAINARD J, GUPTA MK. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer. J Clin Endocrinol Metab 2007; 92: 468-475.
52. SOLINI A, CUCCATO S, FERRARI D, SANTINI E, GULINELLI S, CALLEGARI MG, DARDANO A, FAVIANA P, MADEC S, DI VIRGILIO F, MONZANI. Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? Endocrinology 2008; 149: 389-396.
53. BINOY K, MOHANTY MS, TRUPTIREKHA S. Autoimmune thyroid failure is higher than usual among thyroid antibody-positive individuals on a more than adequate or excessive iodine diet. Indian J Clin Biochem 2005; 20: 9-17.
54. LI Y, TENG D, SHAN Z, TENG X, GUAN H, YU X, FAN C, CHONG W, YANG F, DAI H, GU X, YU Y, MAO J, ZHAO D, LI J, CHEN Y, YANG R, LI C, TENG W. Antithyroperoxidase and antithyroglobulin antibodies in a five- year follow-up survey of populations with different iodine intakes. J Clin Endocrinol Metab 2008; 93: 1751-1757.